• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国急性失代偿性心力衰竭患者住院的 10 年生存率和与死亡率增加相关的因素。

Ten-year survival and factors associated with increased mortality in patients admitted for acute decompensated heart failure in Thailand.

机构信息

Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Division of Cardiology, Department of Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand.

出版信息

Singapore Med J. 2020 Jun;61(6):320-326. doi: 10.11622/smedj.2019108. Epub 2019 Sep 6.

DOI:10.11622/smedj.2019108
PMID:31489430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7905128/
Abstract

INTRODUCTION

Data on the long-term outcomes of Asian patients admitted for acute decompensated heart failure is scarce. The objectives of this study were to determine short-term, intermediate-term and long-term survival among patients admitted for acute decompensated heart failure in Thailand, and to identify factors independently associated with increased mortality.

METHODS

Patients who were admitted with a primary diagnosis of heart failure were enrolled in the Thai Acute Decompensated Heart Failure Registry (ADHERE) from 18 hospitals located across Thailand during 2006. Medical record data was collected according to ADHERE protocol. Mortality data was collected from death certificates on file at the Thailand Bureau of Registration Administration.

RESULTS

A total of 1,451 patients were included. The mean age of the patients was 63.7 ± 14.4 years, and 49.7% were male. One-year, five-year and ten-year mortality rates in Thai patients admitted for acute decompensated heart failure were 28.0%, 58.2% and 73.3%, respectively. Independent predictors of increased mortality were identified. There were more cardiovascular-related deaths than non-cardiovascular-related deaths (54.6% vs. 45.4%, respectively).

CONCLUSIONS

The ten-year mortality rate in Thai patients admitted for acute decompensated heart failure was 73.3%. Many factors were found to be independently associated with increased mortality, including left ventricular ejection fraction.

摘要

简介

亚洲急性失代偿性心力衰竭患者的长期预后数据稀缺。本研究旨在确定泰国急性失代偿性心力衰竭患者的短期、中期和长期生存率,并确定与死亡率增加相关的独立因素。

方法

2006 年,来自泰国 18 家医院的患者按照急性失代偿性心力衰竭登记研究(ADHERE)的协议被纳入该研究。根据 ADHERE 协议收集病历数据。死亡率数据来自泰国登记管理局的死亡证明。

结果

共纳入 1451 例患者。患者的平均年龄为 63.7 ± 14.4 岁,49.7%为男性。泰国急性失代偿性心力衰竭患者的 1 年、5 年和 10 年死亡率分别为 28.0%、58.2%和 73.3%。确定了增加死亡率的独立预测因素。心血管相关死亡多于非心血管相关死亡(分别为 54.6%和 45.4%)。

结论

泰国急性失代偿性心力衰竭患者的 10 年死亡率为 73.3%。许多因素被发现与死亡率增加独立相关,包括左心室射血分数。

相似文献

1
Ten-year survival and factors associated with increased mortality in patients admitted for acute decompensated heart failure in Thailand.泰国急性失代偿性心力衰竭患者住院的 10 年生存率和与死亡率增加相关的因素。
Singapore Med J. 2020 Jun;61(6):320-326. doi: 10.11622/smedj.2019108. Epub 2019 Sep 6.
2
Predictors of in-hospital mortality in acute decompensated heart failure (Thai ADHERE).急性失代偿性心力衰竭患者院内死亡的预测因素(泰国急性失代偿性心力衰竭注册研究)
J Med Assoc Thai. 2013 Feb;96(2):157-64.
3
Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.急性失代偿性心力衰竭中免疫反应性B型利钠肽水平的时机与治疗延迟:一项ADHERE(急性失代偿性心力衰竭国家注册研究)分析
J Am Coll Cardiol. 2008 Aug 12;52(7):534-40. doi: 10.1016/j.jacc.2008.05.010.
4
Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure.急性心力衰竭住院后长期生存情况--急性失代偿性慢性心力衰竭和新发急性心力衰竭预后的差异。
Int J Cardiol. 2013 Sep 20;168(1):458-62. doi: 10.1016/j.ijcard.2012.09.128. Epub 2012 Oct 13.
5
Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.射血分数保留的心力衰竭失代偿期中心肌肌钙蛋白升高的相关因素及其预后意义:美国心脏协会 Get With The Guidelines-Heart Failure 项目的研究结果。
JAMA Cardiol. 2017 Feb 1;2(2):136-145. doi: 10.1001/jamacardio.2016.4726.
6
Gender Differences in Anemia and Survival in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.射血分数保留或降低的急性失代偿性心力衰竭住院患者贫血与生存的性别差异
Am J Cardiol. 2017 Aug 1;120(3):435-442. doi: 10.1016/j.amjcard.2017.04.043. Epub 2017 May 11.
7
Association of Hospital Performance Based on 30-Day Risk-Standardized Mortality Rate With Long-term Survival After Heart Failure Hospitalization: An Analysis of the Get With The Guidelines-Heart Failure Registry.基于 30 天风险标准化死亡率的医院绩效与心力衰竭住院后长期生存的关联:对 Get With The Guidelines-Heart Failure 注册研究的分析。
JAMA Cardiol. 2018 Jun 1;3(6):489-497. doi: 10.1001/jamacardio.2018.0579.
8
Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.出院后1年内肾功能恶化是急性失代偿性心力衰竭全因死亡率的一个强有力的独立预测因素。
J Am Heart Assoc. 2014 Nov 4;3(6):e001174. doi: 10.1161/JAHA.114.001174.
9
Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.泰国成年肥厚型心肌病患者的死亡模式和临床结局。
BMC Cardiovasc Disord. 2019 Jan 3;19(1):1. doi: 10.1186/s12872-018-0984-0.
10
Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure.螺内酯类药物受体拮抗剂的使用与老年急性失代偿性心力衰竭患者全因死亡率和再入院率的关系。
JAMA Netw Open. 2019 Jun 5;2(6):e195892. doi: 10.1001/jamanetworkopen.2019.5892.

引用本文的文献

1
Adding Tolvaptan in the Inpatient Treatment for Patients with Heart Failure and Hyponatremia: Budget Impact Analysis in Thailand.在心力衰竭合并低钠血症患者的住院治疗中加用托伐普坦:泰国的预算影响分析
Clinicoecon Outcomes Res. 2025 Jul 16;17:485-494. doi: 10.2147/CEOR.S503735. eCollection 2025.
2
Medication and Outcome in Older Heart Failure Patients: Results from a Prospective Cohort Study.老年心力衰竭患者的药物治疗与预后:一项前瞻性队列研究的结果
Pharmaceuticals (Basel). 2024 May 30;17(6):711. doi: 10.3390/ph17060711.
3
Real-World Clinical Burden of Newly Diagnosed Heart failure in Thai Patients.泰国患者新诊断心力衰竭的真实世界临床负担
Cardiol Ther. 2024 Jun;13(2):415-430. doi: 10.1007/s40119-024-00366-5. Epub 2024 May 6.
4
Heart Failure and Multimorbidity in Asia.心力衰竭与亚洲的多病共存现象
Curr Heart Fail Rep. 2023 Feb;20(1):24-32. doi: 10.1007/s11897-023-00585-2. Epub 2023 Feb 22.
5
Outcomes and predictors of one-year mortality in patients hospitalized with Acute Heart Failure.急性心力衰竭住院患者一年死亡率的结局与预测因素
Int J Cardiol Heart Vasc. 2022 Nov 30;43:101159. doi: 10.1016/j.ijcha.2022.101159. eCollection 2022 Dec.
6
The efficacy and safety outcomes of cardiac resynchronization therapy in patients with heart failure in Thailand: Phramongkutklao experience.泰国心力衰竭患者心脏再同步治疗的疗效和安全性结果:诗丽吉王后国家心脏中心的经验
J Arrhythm. 2021 Dec 19;38(1):126-136. doi: 10.1002/joa3.12667. eCollection 2022 Feb.
7
A psychometric evaluation of the Caregiver Contribution to Self-Care of Heart Failure Index in a Thai population.泰语人群中心力衰竭自我护理贡献量表的心理计量学评估。
Health Qual Life Outcomes. 2021 Jul 10;19(1):177. doi: 10.1186/s12955-021-01814-9.

本文引用的文献

1
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.11 个亚洲地区心力衰竭患者的多病共存情况:使用 ASIAN-HF 注册研究的前瞻性队列研究。
PLoS Med. 2018 Mar 27;15(3):e1002541. doi: 10.1371/journal.pmed.1002541. eCollection 2018 Mar.
2
Heart failure: preventing disease and death worldwide.心力衰竭:全球范围内预防疾病与死亡
ESC Heart Fail. 2014 Sep;1(1):4-25. doi: 10.1002/ehf2.12005.
3
Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study.全球心力衰竭患者的死亡率变化:来自国际充血性心力衰竭(INTER-CHF)前瞻性队列研究的结果。
Lancet Glob Health. 2017 Jul;5(7):e665-e672. doi: 10.1016/S2214-109X(17)30196-1. Epub 2017 May 3.
4
Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.医生的指南遵循与射血分数降低的心力衰竭门诊患者的更好预后相关:QUALIFY 国际注册研究。
Eur J Heart Fail. 2017 Nov;19(11):1414-1423. doi: 10.1002/ejhf.887. Epub 2017 Apr 30.
5
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新:美国心脏病学会/美国心脏协会临床实践指南工作组及美国心力衰竭学会的报告
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi: 10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.
6
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study.心力衰竭患者血管紧张素转换酶抑制剂和β受体阻滞剂加量的决定因素和临床转归:一项前瞻性欧洲研究。
Eur Heart J. 2017 Jun 21;38(24):1883-1890. doi: 10.1093/eurheartj/ehx026.
7
Understanding the Epidemiology of Heart Failure to Improve Management Practices: An Asia-Pacific Perspective.从亚太地区视角理解心力衰竭的流行病学以改善管理实践
J Card Fail. 2017 Apr;23(4):327-339. doi: 10.1016/j.cardfail.2017.01.004. Epub 2017 Jan 19.
8
Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry.亚洲心力衰竭患者的区域和种族差异:亚洲心力衰竭中的心脏性猝死注册研究。
Eur Heart J. 2016 Nov 1;37(41):3141-3153. doi: 10.1093/eurheartj/ehw331. Epub 2016 Aug 7.
9
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗特别工作组。由ESC心力衰竭协会(HFA)特别贡献制定。
Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20.
10
Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction.沙库巴曲缬沙坦钠联合治疗与依那普利治疗射血分数降低的心力衰竭的成本效果比较。
JACC Heart Fail. 2016 May;4(5):392-402. doi: 10.1016/j.jchf.2016.02.007. Epub 2016 Mar 30.